Active	Status	Sponsor type	Region	Phase	Filter
1 Active 2 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Steglujan (ertugliflozin/sitagliptin) / Pfizer, Merck (MSD)
CEASE, NCT05556291: Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability ( Diabetes) Study	Recruiting	N/A	190	RoW	Combinations of Oral Blood Glucose Lowering Drugs	Getz Pharma, Primary Care Diabetes Association, Pakistan	Efficacy, Safety, Tolerability	12/23	12/23